At Ferring Pharmaceuticals, we help people around the world build families and live better lives. We are entrepreneurial and innovative, with a global team focused on scientific advances in the areas of reproductive and women’s health, gastroenterology and urology. Ferring + You is all about working together and sharing ideas, so that we can bring science to life for patients around the world.
Our Commercial teams collaborate as trusted partners with patient groups, clinicians, policy makers and the scientific community to identify and develop new opportunities to help patients. Customer centric, we offer an empowering, entrepreneurial culture – and a place to thrive and grow.
As part of this ambition, we continue to strengthen our presence in Uro-Oncology, building on an established portfolio and preparing for an exciting private market launch planned for 2027. To support this, we are shaping a lean, high-impact field team focused on enabling commercial access to an innovative intravesical gene therapy — the first of its kind to be licensed in the UK. This role offers the opportunity to play a key part in introducing a first-in-class treatment within a focused, specialist market.
Ferring+You
This is a national field-based role focused entirely on the private oncology and urology market. As National Key Account Manager (KAM) will be responsible for establishing and managing relationships with the specialist urologists, oncologists and multidisciplinary teams across a defined network of private cancer centres — principally in London and the South East, with national coverage across a further five to six regional centres.
Your primary objective is to secure and accelerate patient access to a novel intravesical gene therapy launching in 2027 — working through private medical insurers, specialist private hospital networks and self-funding patient pathways. This is not a volume-driven detailing role. It is a high-value, high-complexity key account management position requiring strategic relationship management, commercial acumen and deep understanding of how private oncology operates in the UK.
You will work closely with the Commercial Lead - Uro-Oncology on access strategy and insurer engagement, and with the Field Medical Advisor - Uro-Oncology on clinical education and KOL development.
Your day at Ferring
Account Management & Access (60%)
Build, manage and develop relationships with target urologists, uro-oncologists and MDT leads across approximately 8 private specialist centres nationally
Secure formulary inclusion, prescriber engagement and patient access pathways within each target account
Navigate private hospital procurement, pharmacy and governance processes to enable product availability at launch
Identify and resolve access barriers at account level — including PMI prior authorisation requirements, pharmacy stocking and clinical governance approvals
Maintain accurate and current account plans for each target centre with clear access milestones, stakeholder maps and activity records
Private Insurer Engagement (20%)
Support the Portfolio Lead in insurer engagement — providing field intelligence on insurer coverage decisions, prior authorisation outcomes and patient funding challenges
Act as the field interface between prescribing urologists and insurer medical teams where clinical justification or appeals processes are required
Gather and report real-world coverage data to inform the ongoing insurer access strategy
Commercial Execution & Reporting (10%)
Track and report account-level sales activity, patient starts, insurer coverage outcomes and access milestones
Contribute to quarterly business reviews with accurate field intelligence, account-level analysis and market insight
Manage territory budget (meetings, materials, travel) within agreed parameters and compliance requirements
KOL & Clinical Stakeholder Development (10%)
Identify, develop and maintain relationships with key opinion leaders in private urology and uro-oncology
Support clinical education activities, advisory boards and congress engagement in partnership with the MSL
Provide field-based intelligence on clinical sentiment, competitive activity and evolving treatment pathways
What This Role Offers
The opportunity to be the commercial lead on the UK private market launch of a first-in-class intravesical gene therapy — a genuinely career-defining assignment
A focused, high-value account universe — quality over quantity, strategic over transactional
Close working relationship with a senior commercial team and direct exposure to launch strategy
Real autonomy and ownership in a lean, entrepreneurial environment
Behind our innovation…There’s you
Significant experience in a KAM or specialist sales role within oncology, haematology or a high-value specialty therapy area
Proven track record of navigating private market access — PMI reimbursement, private hospital networks or high-cost therapy commissioning pathways
Experience working with high-cost, low-volume specialty products where access complexity is the primary commercial challenge
Strong commercial and financial acumen — able to articulate budget impact arguments and value propositions to clinical and non-clinical stakeholders
Self-starter with the ability to operate independently in a lean team without traditional sales infrastructure
Excellent relationship management skills — credible and confident with senior clinicians, medical directors and insurer personnel
Full UK driving license
A plus if you also have:
Direct experience in bladder cancer, urological cancers or intravesical therapy — existing relationships with UK private urology centers a significant advantage.
Experience in CAR-T, cell and gene therapy or other ATMP commercial environments — familiarity with BUPA List A, specialist commissioning or complex funding pathways.
Experience launching a new product in the UK private market from pre-launch through to established access.
Existing network across London private oncology/urology (Royal Marsden, HCA, LOC/Harley Street, The Christie).
People come first at Ferring
Get inspired from our commitment to advocate for everyone’s right to build a family, no matter who you are, where you live or who you love
Our inclusive support package – “Building Families at Ferring” provides equal and accessible policies for all employees who wish to start their family journey, ensuring a global standard, irrespective of location and role. Parental leave for both birthing and non-birthing parents
Extended support on family building journey
Making a difference in the life of millions of people means we succeed by working together. Our diverse backgrounds, experiences, expertise, and perspectives enable us to find solutions to even the most challenging problems, and our success is tied to each team member’s contributions. Imagine the power of your career when it’s Ferring + You.
Behind our purpose… There’s you
If our mission and your vision are aligned, please apply!
We strive to build and maintain an inclusive and diverse workplace with equal opportunities and mutual respect for all employees regardless of their backgrounds and socioeconomic status.
Note to agencies: this search is being managed by Ferring’s Talent Acquisition team. Kindly do not send us spontaneous profiles.
Location:Ferring UKSkills Required
- Significant experience in a KAM or specialist sales role within oncology, haematology or a high-value specialty therapy area
- Proven track record in navigating private market access
- Strong commercial and financial acumen
- Excellent relationship management skills
- Full UK driving license
Ferring Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Ferring Pharmaceuticals and has not been reviewed or approved by Ferring Pharmaceuticals.
-
Parental & Family Support — Family-building support includes fertility coverage, surrogacy reimbursement, adoption assistance, concierge support, and a global standard of up to 26 weeks of equal paid parental leave. Repeated external recognition for adoption support underscores this as a standout strength.
-
Leave & Time Off Breadth — Paid parental leave and robust paid time off are emphasized alongside additional time-away practices such as year-end downtime. Strong time-off provisions help bolster overall benefits value.
-
Healthcare Strength — Core medical, dental, and vision coverage is paired with EAP and wellbeing resources. Additional programs like fitness reimbursement and discounts broaden the health and financial support available.
Ferring Pharmaceuticals Insights
What We Do
Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine and maternal health, and in areas of gastroenterology and urology. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring was founded in 1950 and employs more than 7,000 people worldwide. The company is headquartered in Saint-Prex, Switzerland, and has operating subsidiaries in more than 50 countries which markets its medicines in over 100 countries. Community guidelines available here: https://re.ferring.com/Ferring-LinkedIn-Community-Guidelines Social Media Privacy Notice available here: https://www.ferring.com/social-media-privacy-notice/









